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Introduction
Dominant optic atrophy is a progressive eye disease resulting 
from degeneration of the retinal ganglion cell layer with ascend-
ing atrophy of the optic nerve. The disease is most often caused 
by mutations in the OPA1 gene, which encodes a human homo-
logue of yeast Mgm1 (Votruba, 2004). Mgm1 and Opa1 are 
members of the dynamin family of GTP-binding proteins (van 
der Bliek, 1999). The mitochondria of yeast Mgm1 mutants are 
fragmented because of a defect in mitochondrial fusion (Meeusen 
and Nunnari, 2005; Meeusen et al., 2006). Transfection of mam-
malian cells with Opa1 siRNA or with dominant interfering 
constructs also causes mitochondria to fragment. In addition, 
the loss of Opa1 causes cell death, suggesting an antiapoptotic 
function that may contribute to dominant optic atrophy (Olichon 
et al., 2003; Griparic et al., 2004; Arnoult et al., 2005).
Yeast Mgm1 and mammalian Opa1 have N-terminal mito-
chondrial targeting signals that are cleaved by the mitochondrial 
matrix processing protease. Yeast Mgm1 and mammalian Opa1 
reside in the mitochondrial intermembrane space, where they 
are tightly bound to or embedded in the inner membrane (Wong 
et al., 2003). A substantial fraction of yeast Mgm1 is further 
processed by a rhomboid protease called Pcp1, which is required 
for normal Mgm1 function (van der Bliek and Koehler, 2003). 
Yeast Pcp1 mutants can be rescued by the heterologous expression 
of a mammalian Pcp1 homologue called presenilin-associated 
rhomboid-like (PARL; McQuibban et al., 2003). However, only 
4% of Opa1 is processed by PARL (Cipolat et al., 2006; Frezza 
et al., 2006), whereas a much larger fraction of Opa1 is cleaved 
by a protease that is induced with the loss of mitochondrial 
membrane potential or apoptosis (Duvezin-Caubet et al., 2006; 
Ishihara et al., 2006). Moreover, PARL knockout cells have nor-
mal mitochondrial morphologies (Cipolat et al., 2006), whereas 
cells with an induced proteolysis of Opa1 have fragmented 
mitochondria (Duvezin-Caubet et al., 2006), suggesting different 
roles for PARL in mammals and yeast.
Experiments with the heterologous expression of mamma-
lian Opa1 in yeast suggest that a mitochondrial matrix protease 
called paraplegin can process Opa1, but paraplegin siRNA has 
only modest effects on Opa1 in mammalian cells (Ishihara et al., 
2006). The N terminus of mammalian Opa1 also undergoes 
  extensive alternative slicing near the point of cleavage (Satoh 
et al., 2003). Cleavage could conceivably affect the attachment 
of Opa1 to the membrane because Opa1 is released from mito-
chondria coincident with the cleavage that occurs during apop-
tosis (Arnoult et al., 2005). The mechanism of release and its 
functional consequences are not yet known.
In this study, we confi  rm the release of Opa1 during apop-
tosis and show that this coincides with the proteolytic cleavage 
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of Opa1. Transfection with PARL siRNA and PARL knockout 
did not affect Opa1 maturation nor did it affect induced proteol-
ysis, suggesting that other proteases are responsible for these 
cleavages. Investigation of known mitochondrial proteases by 
transfection with siRNA shows that the mitochondrial inter-
membrane space protease Yme1 affects the constitutive pro-
cessing of Opa1. Yme1 also affects mitochondrial morphology, 
but this property is independent of Opa1.
Results and discussion
Inducible proteolysis and release of Opa1
Mature Opa1 can be resolved into fi  ve bands ranging in size from 
85 to 100 kD on Western blots (Fig. 1 A). The bands, which are 
named a through e, correspond to different isoforms (Olichon 
et al., 2007). Treatment with apoptosis-inducing agents causes the 
larger isoforms to disappear from mitochondrial fractions, whereas 
shorter isoforms appear in the cytosol (unpublished data). This 
shift is not affected by cycloheximide, indicating that Opa1 under-
goes inducible proteolysis and release from mitochondria rather 
than altered protein synthesis. Release of Opa1 occurs in the 
presence of the caspase inhibitor zVAD-fmk like release of 
cytochrome c but unlike that of apoptosis-inducing factor, which is 
inhibited by zVAD-fmk (Table S1, available at http://www.jcb.org/
cgi/content/full/jcb.200704112/DC1). Opa1 proteolysis also oc-
curs within 12 min after adding carbonyl cyanide m-chlorophenyl 
hydrazone (CCCP), which induces the loss of mitochondrial 
membrane potential. The mitochondria of CCCP-treated cells 
convert to an abundance of tiny fragments similar to the fragmen-
tation that occurs during apoptosis (Fig. 1 B). However, CCCP 
does not cause the release of Opa1 or cytochrome c into the cyto-
sol nor does it trigger apoptosis even after 5.5 h of incubation, 
as shown by the lack of caspase 9 cleavage (Fig. 1 A). CCCP-
induced cleavage is also not enough to release Opa1 from the inner 
membrane because a substantial fraction of the cleaved protein re-
mains membrane bound, as determined with carbonate extraction 
(unpublished data). Removal of CCCP allows for the gradual 
  recovery of wild-type mitochondrial morphology and of the lar-
ger Opa1 isoforms (Fig. S1). This recovery is blocked by cyclo-
heximide, showing that it requires the de novo synthesis of Opa1.
siRNA of mitochondrial proteases
To fi nd out which proteases affect Opa1, we conducted knockdown 
experiments with siRNA directed against known mitochondrial 
Figure 1.  The loss of mitochondrial mem-
brane potential is enough to induce Opa1 
proteolysis. (A) Western blots of cells treated 
for increasing lengths of time with CCCP show 
a shift in Opa1 isoforms. Tim23 serves as a 
loading control. Lack of cleavage of caspase 9 
shows that CCCP did not induce apoptosis. 
Staurosporine (STS)-induced cleavage serves 
as a positive control. Opa1 bands were la-
beled a, b, c, d, and e as previously described 
(Duvezin-Caubet et al., 2006; Ishihara et al., 
2006; Olichon et al., 2007). (B) A 5.5-h incuba-
tion with CCCP causes mitochondria to fragment 
but does not cause the release of cytochrome c 
or Opa1 into the cytosol. The merged images 
show cytochrome c in red and Opa1 in green. 
Bar, 10 μm.REGULATION OF OPA1 BY PROTEOLYSIS • GRIPARIC ET AL. 759
proteases. The rhomboid protease PARL was considered a likely 
candidate because it is very similar to yeast Pcp1. PARL siRNA 
was highly effective (Fig. 2 A). However, transfection with 
PARL siRNA had no effect on Opa1 maturation or inducible 
proteolysis. Because a small amount of residual PARL could 
still account for inducible cleavage, we also tested a PARL 
knockout mouse embryonic fi  broblast cell line (Cipolat et al., 
2006). We fi  nd that PARL
−/− cells already show a substantial 
amount of Opa1 proteolysis even without CCCP. This cleavage 
may refl  ect the increased susceptibility to apoptosis that was 
previously observed with PARL
−/− mice (Cipolat et al., 2006) 
and by us with PARL siRNA (unpublished data). However, this 
cell line is still capable of inducible cleavage (Fig. 2 C). The ex-
istence of inducible cleavage in these cells was confi  rmed by 
transfection with selected Opa1 isoforms and treatment with 
CCCP. Overexpression of Opa1 isoform 7 in PARL knockout 
cells showed some changes in the intensities of bands c and d 
(Fig. 2 C, bottom), but these intensities varied between experi-
ments, suggesting that PARL is not required for constitutive 
cleavage nor is it required for inducible cleavage.
Another candidate is HtrA2/Omi, which faces the mito-
chondrial intermembrane space (Seong et al., 2004). HtrA2/Omi 
siRNA was highly effective (>99.4% reduction as judged by 
densitometry of the Western blot), but this did not noticeably 
Figure 2.  Effects of known mitochondrial proteases on Opa1 proteolysis. (A) Cells were transfected with siRNA for the different proteases. Scrambled 
  oligonucleotides served as controls. PARL was reduced by 92%, Yme1 was reduced by 72%, and HtrA2/Omi was reduced by 99.4% on Western blots. 
Proteolysis was induced with CCCP (60 min). DMSO (solvent) served as a control. For Yme1 and PARL siRNA, proteolysis was also induced with staurosporine 
(3 h). Data are representative of three independent experiments. (B) Densitometry of Opa1 bands in Yme1 siRNA–transfected cells with or without CCCP. 
The histogram shows the relative intensity of bands. (C) PARL
−/− cells show enhanced degradation but still possess the inducible cleavage of Opa1. Endog-
enous protein was detected with Opa1 antibody. Transfected isoforms were detected with a C-terminal myc tag. The two cleavage products of isoform 7 
correspond to cleavage in exon 5 (S1) and exon 5b (S2). (D) Effects of Yme1 siRNA on isoform 1, 5, and 7 cleavage with or without CCCP induction and 
deletion of the S1 cleavage site. (E) Densitometry of the uninduced lanes (DMSO) in D. A plus symbol after Delta S1 indicates an S1 cleavage site deletion 
(Ishihara et al., 2006). A plus symbol after Yme1 indicates transfection with Yme1 siRNA.JCB • VOLUME 178 • NUMBER 5 • 2007  760
affect Opa1 proteolysis (Fig. 2 A). Lastly, we tested mitochon-
drial AAA proteases. Mammals have three of these, namely 
Yme1, paraplegin, and AFG3L2 (Langer et al., 2001). The cata-
lytic domain of Yme1 faces the mitochondrial intermembrane 
space, whereas those of paraplegin and AFG3L2 face the mito-
chondrial matrix. Transfection with paraplegin and AFG3L2 
siRNA did not affect Opa1 proteolysis, but knockdown was 
  incomplete (10 and 34% residual RNA), so paraplegin or AFG3L2 
might still mediate inducible cleavage.
In contrast, Yme1 siRNA did affect Opa1 even without 
CCCP. Western blots show shifts in banding patterns in treated 
and untreated cells (Fig. 2 A). CCCP still induces proteolysis 
in Yme1 siRNA–transfected cells, whereas not all bands are 
equally affected by Yme1 siRNA and CCCP (Fig. 2 B), sug-
gesting that the cleavage patterns are governed by alternative 
splicing. We conclude that Yme1 affects the constitutive prote-
olysis of a subset of Opa1 isoforms but is not required for in-
ducible proteolysis.
Opa1 has extensive alternative splicing near the sites of 
cleavage (Ishihara et al., 2006). To determine which splice vari-
ants are affected by inducible proteolysis and which are affected 
by Yme1-mediated proteolysis, we transfected cells with repre-
sentative expression constructs (isoform 1 has no extra exon, 
isoform 5 has 4b but not 5b, and isoform 7 has 5b but not 4b; 
  Satoh et al., 2003). All three isoforms are relatively abundant in 
HeLa cells (Satoh et al., 2003; Olichon et al., 2007). In addition, 
we transfected cells with expression constructs in which the ma-
jor inducible cleavage site S1, which is contained by exon 5, was 
deleted (Ishihara et al., 2006). The transfected cells were treated 
with or without CCCP to determine their sensitivity to inducible 
proteolysis and were cotransfected with or without Yme1 siRNA 
to determine their sensitivity to constitutive proteolysis.
Our results confi  rm that isoform 1 is cleaved by CCCP-
  inducible proteolysis (Fig. 2, D and E). Mutations in S1, the 
cleavage site that was previously shown to exist in exon 5, ren-
der this isoform insensitive to inducible cleavage (Ishihara et al., 
2006). However, this isoform is not affected by Yme1 siRNA. 
In contrast, isoform 5 and isoform 7, which contain exon 4b and 
exon 5b, respectively, are affected by Yme1 siRNA. In both 
cases, there is a substantial shift to the uncleaved band. Residual 
cleavage to the lower bands in uninduced cells and further 
cleavage upon induction with CCCP can be attributed to the 
 inducible  protease.
Isoform 5, which contains exon 4b, is fully cleaved even 
without CCCP induction (Fig. 2, D and E). This cleavage is re-
duced but not fully eliminated by deleting S1, and it is reduced 
but not fully eliminated by transfection with Yme1 siRNA. 
However, the uncleaved protein that accumulates under these 
conditions can be cleaved by inducible proteolysis even when 
S1 is deleted. We conclude that isoform 5 has an alternative 
cleavage site similar to the alternative cleavage site in isoform 7. 
Sizing by SDS-PAGE suggests that this site is in exon 4b (un-
published data), which is analogous to the alternative cleavage 
site S2 in exon 5b of isoform 7.
Isoform 7 yields three bands (uncleaved protein and two 
cleavage products), which is consistent with previous results 
(Ishihara et al., 2006). The longer cleavage product refl  ects 
a cleavage site (S1) in exon 5, and the shorter product refl  ects 
a cleavage site (S2) in exon 5b. The deletion of S1 abolishes the 
longer cleavage product, and it causes an accumulation of un-
cleaved protein. This uncleaved protein is poorly cleaved upon 
treatment with CCCP, suggesting that the S2 site is less effi  -
ciently cleaved by the inducible protease. Similar results were 
obtained with Yme1 siRNA. The uncleaved protein that accu-
mulates with Yme1 siRNA is preferentially cleaved at S1 upon 
induction with CCCP (Fig. 2 D, bottom; lanes 5 and 6).
To confi  rm that exon 4b– and 5b-containing isoforms are 
affected by Yme1, we transfected cells with siRNA oligonucle-
otides that are specifi  c for exons 4b and 5b as described previ-
ously (Olichon et al., 2007). Exon 4b and 5b siRNA both reduce 
the intensity of band d (Fig. S2 A, available at http://www.jcb.org/
cgi/content/full/jcb.200704112/DC1). Exon 5b siRNA also 
reduces the intensity of bands a and c, although these are al-
ready faint in wild-type cells. Transfection with Yme1 siRNA 
produces a pattern that appears to be the sum of exon 4b and 5b 
siRNA alone. We conclude that the shorter products in un-
induced cells consist of isoforms with exon 4b or 5b. These iso-
forms require Yme1 for constitutive cleavage, whereas the other 
isoforms remain susceptible to inducible cleavage.
Effects of Yme1 and Opa1 isoform-speciﬁ  c 
siRNA on mitochondrial morphology
To our surprise, the mitochondria of cells transfected with Yme1 
siRNA are unusually connected (Fig. 3, C and D). 2 d after 
transfection, 40% of cells had more connected mitochondria, 
56% appeared normal, and 4% had fragmented mitochondria 
(n = 400), whereas in untransfected cells, 100% of the mito-
chondria had normal morphologies (n = 100). Similar morpho-
logical defects were observed with two other Yme1 siRNA 
oligonucleotides (Fig. S2, B–D), confi  rming that these effects 
were specifi  c for the knockdown of Yme1. The increased con-
nectivity is strikingly similar to the connectivity observed with 
Drp1 siRNA (Fig. 3 B). At later times, a substantial fraction of 
cells undergo cell death (Fig. S2 E), and the mitochondria frag-
ment (3 d after transfection, 23% of cells had connected mito-
chondria and 45% were normal, whereas 31% had fragmented 
mitochondria; n = 300). These fragments are more irregular 
than the mitochondrial fragments in Opa1 siRNA cells (Fig. 3, 
E and F). Similar mitochondrial disintegration is observed with 
strong Drp1 mutants at later time points (Smirnova et al., 2001).
To determine whether the increased connectivity of Yme1 
siRNA cells is caused by an increase in fusion or a decrease in 
division, we induced mitochondrial fragmentation by incubat-
ing transfected cells with CCCP and allowing them to recover 
(similar to the cycloheximide experiment; Fig. S1). We fi  nd that 
transfection with Yme1 siRNA does not prevent CCCP-induced 
fragmentation nor does it prevent recovery after washout (Fig. 4, 
A–F). Quantitation of these results suggests that there is some 
delay in recovery (Fig. 4 G), but the fact that recovery can occur 
at all suggests that Yme1 is not necessary for mitochondrial fusion. 
The observation that CCCP can still induce mitochondrial frag-
mentation in Yme1 siRNA cells unlike cells transfected with 
dominant-negative mutants of Drp1 (Duvezin-Caubet et al., 
2006) suggests that mitochondrial fi  ssion can still occur as well. REGULATION OF OPA1 BY PROTEOLYSIS • GRIPARIC ET AL. 761
The morphological abnormalities that we observe in Yme1 
siRNA cells must therefore result from a subtle shift in the bal-
ance between mitochondrial fi  ssion and fusion rather than from 
strong effects on either process.
Comparable morphological abnormalities were also ob-
served with Opa1 exon 4b– and 5b-specifi  c siRNA (Olichon 
et al., 2007). Transfection with these oligonucleotides increases 
mitochondrial connectivity (Fig. 3, I and J), but there are small 
differences between the morphologies observed with exon 4b 
and 5b siRNA. Exon 4b siRNA gives rise to thin and more con-
nected mitochondria, whereas exon 5b gives rise to connected 
mitochondria with localized swellings, similar to Yme1 siRNA. 
In addition, Opa1 exon 4b– and 5b-specifi  c siRNA increase the 
number of apoptotic cells (unpublished data), which is consis-
tent with previously published data (Olichon et al., 2007). To 
determine whether Opa1 is required for the increased con-
nectivity observed with Yme1 siRNA, we cotransfected Yme1 
siRNA and pan-Opa1 siRNA. Western blotting showed an 82% 
reduction of Opa1 levels, which would ordinarily affect mito-
chondrial morphology (Cipolat et al., 2004), and a 99% reduc-
tion of Yme1 levels (see Fig. S3 A for Western blots; available 
at http://www.jcb.org/cgi/content/full/jcb.200704112/DC1). 
Figure 3.  Disruption of mitochondrial morphology by Yme1 
siRNA. Mitochondria were detected with Mitotracker. (A) 
Cells transfected with scrambled oligonucleotides for Yme1. 
(B) A cell 2 d after transfection with Drp1 siRNA. (C and D) 
Cells 2 d after transfection with Yme1 siRNA. (E and F) Cells 
3 d after transfection with Yme1 siRNA. (G) Cells 2 d after 
transfection with Opa1 siRNA. (H) Cells 2 d after cotransfec-
tion with Opa1 and Yme1 siRNA (see Fig. S3 A for expres-
sion levels). (I and J) Cells transfected with Opa1 exon 4b– and 
5b-speciﬁ  c siRNA (see Fig. S2 for quantiﬁ  cation of the mor-
phological defects; available at http://www.jcb.org/cgi/
content/full/jcb.200704112/DC1). Bar, 10 μm.JCB • VOLUME 178 • NUMBER 5 • 2007  762
To our surprise, almost all of the cells that were cotransfected 
with Opa1 and Yme1 siRNA had more connected mitochondria 
(Fig. 3 H), similar to Yme1 siRNA alone, whereas none had 
fragmented mitochondria (n = 200). In contrast, 99% of cells 
that were transfected with Opa1 siRNA alone had fragmented 
mitochondria, as seen previously (Griparic et al., 2004). These 
results suggest that Yme1 is epistatic to Opa1.
We used electron microscopy to examine the effects of 
Yme1 siRNA on the internal structure of mitochondria (Fig. S3, 
C–F). For comparison, cells were also transfected with Drp1 
siRNA and with Yme1 and Opa1 siRNA together. None of these 
transfections had drastic effects on cristae morphology. Yme1 
siRNA did cause some cristae to appear disorganized, but the 
results were not strong nor were they readily quantifi  ed. There 
were also no obvious defects in Yme1/Opa1 double siRNA 
cells. Opa1 siRNA can affect cristae morphology (Griparic et al., 
2004), but this might have been suppressed by the increased 
connectivity caused by Yme1 siRNA. Similar suppression of 
cristae defects was observed in a yeast double mutant of Mgm1 
and Dnm1 (homologues of Opa1 and Drp1; Sesaki et al., 2003). 
We conclude that the internal structures of mitochondria are not 
notably disrupted by Yme1 siRNA.
Functional consequences of 
Opa1 proteolysis
Our results show a distinction between the constitutive cleavage 
of Opa1, which is Yme1 dependent, and inducible cleavage, 
which is Yme1 independent. These two types of cleavage have dif-
ferent effects on different isoforms. The processing of isoforms 5 
(exon 4b) and 7 (exon 5b) requires Yme1, whereas isoform 1 
(neither exon) is unaffected by Yme1. Yme1 renders isoforms 
with exons 4b and 5b insensitive to inducible cleavage, whereas 
the loss of Yme1 with siRNA restores their sensitivity to induc-
ible cleavage. Yme1 could directly cleave Opa1 because both 
proteins are anchored in the mitochondrial inner membrane facing 
the mitochondrial inner membrane space, or the effects could be 
indirect. Based on these results, we propose that the Opa1 iso-
forms fall into two classes: namely, those that are sensitive to 
Yme1 and those that are not.
Although better known for its role in the proteolytic deg-
radation of misfolded proteins (Langer et al., 2001), Yme1 has 
been shown to assist the import and maturation of specifi  c inter-
membrane space proteins (Rainey et al., 2006). However, cells 
transfected with Yme1 siRNA or with exon 4b or 5b siRNA do 
not show an obvious fusion defect. Instead, these transfections 
Figure 4.  Recovery of Yme1 siRNA–trans-
fected cells from CCCP-induced mitochondrial 
fragmentation.  (A–F) Cells were transfected 
with scrambled (A–C) or Yme1 siRNA oligo-
nucleotides (D–F). Mitochondrial morphology 
was observed by cotransfection with mitochon-
drial targeted DsRed. Cells was observed with-
out further treatment at 2 d after transfection 
(A and D), after incubation with CCCP for 60 min 
(B and E), or incubation with CCCP for 60 min 
followed by washout and 3.5-h recovery (C 
and F). (G) Percentages of cells with different 
mitochondrial morphologies and the treatments 
described in A–F. Morphologies were classiﬁ  ed 
as connected (highly interconnected), normal 
(tubular morphology), intermediate (partially 
fragmented), and fragmented (fully fragmented). 
Samples sizes for the scrambled controls were 
as follows: n  = 506 cells counted before 
the addition of CCCP, n = 246 counted after 
adding CCCP, and n = 100 cells counted at 
3.5 h   after washout. Sample sizes for Yme1 
siRNA were n = 384, n = 332, and n = 169, 
respectively. Bar, 10 μm.REGULATION OF OPA1 BY PROTEOLYSIS • GRIPARIC ET AL. 763
lead to novel mitochondrial morphologies that are more similar 
to the morphologies in preapoptotic cells, which is consistent 
with the previously proposed antiapoptotic function of exons 4b 
and 5b (Olichon et al., 2007).
It is not yet clear how Yme1 siRNA affects mitochondrial 
morphology. Yme1 could directly infl  uence mitochondrial fi  s-
sion or fusion, or it could act on a different protein with a domi-
nant effect on mitochondrial morphology. However, increased 
numbers of connections were also observed in Drosophila 
 melanogaster cells treated with ceramide, suggesting that this 
might be a prelude to apoptosis (Goyal et al., 2007). Yme1 
siRNA might then preempt the loss of fusion caused by Opa1 
siRNA in cotransfected cells by increasing the rate of mito-
chondrial fusion or decreasing the rate of fi  ssion at an earlier 
time point. These effects are not absolute, however, because they 
are overridden by treatment with CCCP. A similar dichotomy was 
observed with BH3 proteins such as Bax and Bak, which direct 
mitochondrial fi  ssion during apoptosis but are required for mito-
chondrial fusion in normal cells (Karbowski et al., 2006).
The accompanying paper by Song et al. (see p. 749 of this 
issue) and previous work with yeast (Herlan et al., 2003) show 
that mitochondrial fusion requires both cleaved and uncleaved 
forms of Opa1. Song et al. (2007) show that Yme1 can mediate 
this cleavage, but our data indicate that fusion also occurs with-
out Yme1. The requirement for cleavage, which is shown by 
Song et al. (2007), might instead be met by the inducible prote-
ase. This possibility is intriguing because the inducible protease 
and mitochondrial fusion are both regulated by the mitochon-
drial inner membrane potential (Meeusen et al., 2004). We con-
clude that there are three types of Opa1 cleavage: (1) 
Yme1-dependent processing of Opa1 isoforms with antiapop-
totic functions; (2) cleavage of a fraction of Opa1 protein to 
meet the requirement for fusion; this type of cleavage can be 
mediated by Yme1, but it might also be mediated by the induc-
ible protease; and (3) inducible cleavage of the remaining Opa1 
protein after the loss of membrane potential as it occurs during 
apoptosis. This cleavage probably inactivates Opa1 because it 
coincides with mitochondrial fragmentation.
Materials and methods
Cell culture and microscopy
HeLa cells were cultured as described previously (Griparic et al., 2004). 
Apoptosis was induced with 2 μM staurosporine (Sigma-Aldrich) or 
10 μM actinomycin D (Calbiochem). Where indicated, 100 μM zVAD-fmk 
(Qbiogene) was added 30 min before adding actinomycin D. Mitochondrial 
membrane potential was disrupted with 10 μM CCCP (Sigma-  Aldrich), 
and, where indicated, 20 μg/ml cycloheximide (Calbiochem) was added. 
For the washout experiments, cells were rinsed twice with PBS at 37°C and 
incubated with fresh culture medium. Controls were treated with solvent 
(DMSO). Cells were prepared for immunoﬂ  uorescence as described previ-
ously (Griparic et al., 2004). Opa1 antibody was described previously 
(Griparic et al., 2004). Apoptosis-inducing factor antibody was obtained 
from Santa Cruz Biotechnology, Inc., and cytochrome c antibody was pur-
chased from BD Biosciences. Secondary antibodies were purchased from 
Jackson ImmunoResearch Laboratories and Biomeda. B. De Strooper 
(Katholieke Universiteit Leuven, Leuven, Belgium) provided PARL knockout 
mouse embryonic ﬁ  broblast cells, which were grown as described previ-
ously (Cipolat et al., 2006). Fluorescence microscopy was performed with 
a microscope (Axiovert 200M; Carl Zeiss MicroImaging, Inc.) using an 
α plan-Fluar 100× NA 1.45 oil objective (Carl Zeiss MicroImaging, Inc.). 
Images were acquired with a CCD camera (ORCA ER; Hamamatsu) and 
Axiovision software (Carl Zeiss MicroImaging, Inc.). Image ﬁ  les were 
processed with Photoshop software (Adobe).
Subcellular fractionation and Western blotting
To isolate mitochondria for the Yme1 blots, cells were pelleted by centrifuga-
tion for 5 min at 600 g and washed with mitochondrial isolation buffer 
(Griparic et al., 2004). Cell membranes were disrupted by sonication. Nuclei 
and unbroken cells were removed by centrifugation for 5 min at 1,000 g. 
  Mitochondria were pelleted by further centrifugation for 30 min at 10,000 g. 
Pellets were resuspended in laemmli sample buffer, size fractionated by SDS-
PAGE, and blotted to nitrocellulose.
Cell extracts were produced by direct lysis in laemmli sample buffer. 
After boiling for 5 min, samples were resolved by SDS-PAGE (6% for Opa1 
and 10 or 12% for the other proteins). Blots were probed with mouse 
Opa1 and Tim23 antibodies (BD Biosciences), mouse caspase 9 and PARP 
antibodies (BD Biosciences), caspase 3 antibody (Abcam), Omi antibody 
(BioVision), rat anti-myc antibody (AbD Serotec), goat anti-Hsp60 antibody 
(Santa Cruz Biotechnology, Inc.), and tubulin monoclonal antibody (Sigma-
Aldrich). PARL antibodies were provided by B. De Strooper, and Yme1 anti-
bodies were provided by C. Koehler (University of California, Los Angeles, 
Los Angeles, CA). Blots were developed with HRP-labeled secondary anti-
body and chemiluminescence reagents (GE Healthcare).
Transfection constructs and siRNA oligonucleotides
The expression construct containing wild-type Opa1 isoform 1 was de-
scribed previously (Griparic et al., 2004). A C-terminal myc tag was 
added to this construct by PCR. Isoform 7 was generated by amplifying 
exon 5b from HeLa cDNA and cloning this fragment with BclI and BstBI 
sites in the myc-tagged isoform 1 construct. Isoform 5 was similarly gener-
ated by amplifying exon 4b and surrounding sequences from HeLa cDNA 
and cloning this fragment with BclI and BstBI sites in the myc-tagged iso-
form 1 construct. Deletions in the S1 cleavage site were made with fusion 
PCR using A  G  G  T  T  C  T  C  C  G  G  A  A  G  A  A  T  C  T  G  A  A  A  G  T  G  A  C  A  A  G  C  A  T  T  T  T  A  G   and 
A  A  T  G  C  T  T  G  T  C  A  C  T  T  T  C  A  G  A  T  T  C  T  T  C  C  G  G  A  G  A  A  C  C  T  G  A  G  G  T   primers for 
site-directed mutagenesis. The mutated fragments were cloned into the 
isoform 1, 5, and 7 myc-tagged constructs with BclI and BstBI sites. New 
clones were sequenced to ensure ﬁ  delity.
The oligonucleotides for siRNA were synthesized by Sigma-Proligo. 
Their sequences are G A  T  G  C  A  T  T  T  A  A  A  A  C  T  G  G  T  T  T  T   (ﬁ  rst), A  C  T  T  C  C  A  A  A  A  G  G-
A  A  T  T  C  T  T  T  T   (second), and T  C  T  T  G  T  G  A  A  C  C  A  G  G  C  T  G  C  A  T  T   (third) for Yme1, 
A  T  C  C  A  G  G  G  T  C  C  A  G  A  G  T  T  A  T  T  T   for PARL, G  G  T  C  A  C  A  G  C  T  G  G  A  A  T  C  T  C  C  T  T   
for HtrA2/Omi, G  G  G  A  A  G  G  T  G  G  A  T  T  C  A  G  T  G  C  T  T   and T  C  A  G  C  T  T  A  A  A  A  T  G-
G  C  T  C  G  T  T  T   for paraplegin, T A  T  T  G  G  C  A  G  T  G  T  G  G  A  C  A  C  C  T  T   and G A  A  T  G  C  C-
C  C  T  T  G  C  A  T  C  C  T  C  T  T   for AFG3L2, G  C  A  G  A  A  G  A  A  T  G  G  G  G  T  A  A  A  T  T  T   for Drp1, 
G  A  T  C  A  T  C  T  G  C  C  A  C  G  G  G  T  T  G  T  T   for all Opa1 isoforms, G  T  C  A  T  A  G  G  A  G  C  T  T-
C  T  G  A  C  C  T  A   for Opa1 exon 4b, and G  A  G  G  A  A  G  C  G  C  G  C  A  G  A  G  C  C  G  C  T   
for Opa1 exon 5b of Opa1. Scrambled controls had inverted sense strand 
sequences. HeLa cells were split 1 d before transfection, giving 30–50% 
conﬂ  uency on the next day. Transfection was performed with Oligofectamine 
(Invitrogen) using 60 pmol siRNA duplexes. On day 2, cells were split 1:3 or 
1:4 to 6-cm or glass-bottom dishes and transfected again on day 3. On day 4, 
some cells were used for RNA isolation. Others were incubated with Mito-
Tracker red (Invitrogen) and CCCP. For CCCP recovery with Yme1 siRNA, 
cells were transfected with siRNA and MitoDsRed (CLONTECH Laboratories, 
Inc.) using LipofectAMINE 2000 (Invitrogen).
The effects of siRNA on expression levels were quantiﬁ  ed with real-
time PCR or with Western blotting when antibodies were available. For real-
time PCR, total RNA was isolated with the RNeasy kit (QIAGEN). 200–300 ng 
RNA was reverse transcribed using ThermoScript (Invitrogen). Real-time 
PCR was performed with an ICycler and iQ SYBR green Supermix (Bio-Rad 
Laboratories). Actin mRNA was used as a control. Each sample was mea-
sured in triplicate. Western blots were quantiﬁ  ed with densitometry using a 
Personal Densitometer SI and ImageQuant software (Molecular Dynamics).
Online supplemental material
Fig. S1 shows the CCCP-induced cleavage of Opa1 and recovery after 
washout (A) and that mitochondria also recover their ﬁ  lamentous morphol-
ogy, but not with cycloheximide (B–E). Fig. S2 shows the effects of Yme1 
siRNA on Opa1 and compares this with the effects of exon 4b and 5b 
siRNA (A). Fig. S2 also shows the morphological effects of two additional 
Yme1 siRNA oligonucleotides (B–D) and shows the effects of Yme1 siRNA 
on apoptosis (E). Fig. S3 shows Opa1 and Yme1 in single and double 
siRNA transfections by Western blotting and electron microscopy. Table S1 
presents data on the percentage of cells releasing Opa1, cytochrome c, 
or apoptosis-inducing factor from mitochondria 7 or 10 h after inducing JCB • VOLUME 178 • NUMBER 5 • 2007  764
apoptosis with actinomycin D. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200704112/DC1.
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